Hyderabad, 11th July 2024: Amrita Vishwa Vidyapeetham, a leading university, is all set to commence production of Netravaad, an innovative device designed to revolutionize patient care for individuals with speech impairments. This groundbreaking technology is being developed by T2HInnovations, a healthtech startup incubated under SCTIMST TIMED (TBI for Medical Devices and Biomaterials)
Named Netravaad, the device is developed and tested rigorously at Amrita Hospital in Kochi. Netravaad utilizes innovative eye gesture-based technology to enable patients to communicate their needs effectively.
T2HInnovations, a Kerala-based startup established under the AI and Robotics research center, HuT Labs of Amrita University, specializes in biomedical and healthcare robotics. It operates in close collaboration with Amrita University’s research facilities, leveraging the university’s expertise in engineering and technology to develop impactful solutions such as Netravaad.
Dr. Rajesh Kannan Megalingam, Director, HuT Labs, Amrita Vishwa Vidyapeetham, and Founder, T2H Innovations, said, “We’re now in the production phase of Netravaad and all set to bring this transformative technology to a wider audience. Netravaad’s ability to enable communication through eye gestures represents a major leap for individuals with speech impairments. This milestone reflects our dedication to developing practical solutions that meet the communication needs of millions affected by neurological disorders.”
Amrita University is committed to advancing biomedical technologies to empower individuals, envisioning a future where everyone can engage with the world independently.
